A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study (clinicaltrials.gov) - Oct 20, 2026 - P2 | N=632 | Recruiting | Sponsor: LaNova Medicines Zhejiang Co., Ltd. | N=276 ➔ 632 | Trial completion date: Jul 2028 ➔ Aug 2031 | Trial primary completion date: Jul 2026 ➔ Aug 2031
Enrollment change • Trial completion date • Trial primary completion date • Gastrointestinal Cancer • Oncology • Solid Tumor • CLDN18
|